MARKET

ZLDPF

ZLDPF

Zealand Pharma A/S
OTCPK
34.00
-0.16
-0.47%
Closed 10:37 10/15 EDT
OPEN
34.00
PREV CLOSE
34.16
HIGH
34.00
LOW
34.00
VOLUME
1.78K
TURNOVER
60.45K
52 WEEK HIGH
80.67
52 WEEK LOW
34.00
MARKET CAP
2.26B
P/E (TTM)
5.76
1D
5D
1M
3M
1Y
5Y
1D
Generate, Zealand in collaboration to develop drugs for obesity, metabolic diseases
Seeking Alpha · 2d ago
Generate Biomedicines, Zealand Pharma enter protein therapeutics pact
TipRanks · 2d ago
Weekly Report: what happened at ZLDPF last week (1005-1009)?
Weekly Report · 3d ago
Zealand, Roche release phase 2 topline data for amylin analogue petrelintide
Seeking Alpha · 10/08 22:05
Petrelintide Phase III Trial Puts Zealand Pharma in the Weight-Loss Spotlight
TipRanks · 10/07 16:30
Zealand Pharma Advances Petrelintide Into Phase III, Raising Its Profile in the Obesity Drug Race
TipRanks · 10/07 16:30
Petrelintide Phase III Trial Puts Zealand Pharma in the Obesity–Heart Disease Spotlight
TipRanks · 10/07 16:30
Ironwood Pharmaceuticals: The Stock Is A Call On The Second Apraglutide Trial - Buy
Seeking Alpha · 10/07 11:39
More
About ZLDPF
Zealand Pharma A/S is a Denmark-based biotechnology company. The Company is focused on the discovery, design and development of peptide-based medicines for metabolic and gastrointestinal diseases and other rare disease areas with unmet medical needs. The Company's peptide-based product candidates includes clinical development, registration and, potentially, commercialization. Its pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome, or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for better diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The Company operates in Denmark and the USA and has a portfolio of medicines and product candidates, including collaborations with Boehringer Ingelheim.

Webull offers Zealand Pharma A/S stock information, including OTCPK: ZLDPF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZLDPF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZLDPF stock methods without spending real money on the virtual paper trading platform.